![]() |
市場調査レポート
商品コード
1292924
人工腎臓の世界市場2023-2030Global Artificial Kidney Market 2023-2030 |
||||||
カスタマイズ可能
|
人工腎臓の世界市場2023-2030 |
出版日: 2023年05月22日
発行: Orion Market Research
ページ情報: 英文 145 Pages
納期: 2~3営業日
|
人工腎臓の世界市場は、予測期間中にCAGR 13.0%の大幅な成長が見込まれています。市場成長の要因は、後天性嚢胞性腎臓病、糸球体疾患、糖尿病、その他などの疾患を患う患者が世界的に増加していることです。さらに、腎臓ドナーが少ないことも市場成長を強める重要な要因です。例えば、米国疾病予防管理センター(CDC)によると、2021年には米国成人の7人に1人、つまり15%、3,700万人以上が慢性腎臓病(CKD)と診断されます。
革新的な人工腎臓を製造するための研究開発活動の増加は、人工腎臓市場の成長をさらに後押しすると予想されます。例えば、2021年6月、UCLA Healthは「開発中の人工腎臓は透析のない生活を提供することを目指す」という記事を発表しました。この記事によると、米国保健福祉省(HHS)は腎臓病の予防、診断、治療におけるイノベーションを加速するために米国腎臓学会(ASN)と提携しました。現在、両組織は水を使わない透析液フリー技術の開発に共同で取り組んでおり、2026年までに初の移植可能な人工腎臓の開発を支援しています。
透析タイプ別では、血液透析が世界の人工腎臓市場で大きなシェアを占めると予想されています。血液透析は、血液中の老廃物や水分をろ過する治療法です。血圧(BP)をコントロールし、血液中のカリウム、ナトリウム、カルシウムなどの重要なミネラルのバランスをとるのに役立ちます。同分野の成長は、世界人口の糖尿病や高血圧の増加とともに、末期腎疾患(ESRD)の増加によるものです。米国国立衛生研究所(NIH)によると、2021年には米国で約78万6,000人がESRDを患っています。そのうち71%が透析を受け、29%が腎移植を選ぶと予想されています。
すべての地域の中で、アジア太平洋地域は予測期間中に人工腎臓市場で大きなシェアを占めると予測されています。市場成長を後押しする要因としては、慢性腎臓病に罹患する人々の増加、人工腎臓の生産能力を強化するための地域の主要市場プレイヤーによる投資の増加などが挙げられます。例えば、2020年12月、日本の医療機器メーカーであるニプロアジアは、透析装置に使用される人工腎臓の世界の生産設備を増強するために約9億5,800万米ドルを支出しました。この投資は2026年度までの予定で、主にベトナムと自国市場の工場に投入されます。総生産能力は月産1,200万ユニットに達します。この拡張は、経済成長に伴い糖尿病患者が増加している新興国でのダイアライザーの販売を強化するニプロの計画をサポートします。
業界の現状分析と成長ポテンシャルの展望
人工腎臓の世界市場:エンドユーザー別
透析センター
GLOBAL ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
NORTH AMERICAN ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
EUROPEAN ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
ASIA-PACIFIC ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
REST OF THE WORLD ARTIFICIAL KIDNEY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
GLOBAL ARTIFICIAL KIDNEY FOR PERITONEAL DIALYSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
GLOBAL ARTIFICIAL KIDNEY IN DIALYSIS CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
Global Artificial Kidney Market Size, Share & Trends Analysis Report by Device Type (Wearable Artificial Kidney and Implantable Artificial Kidney), by Dialysis Type (Hemodialysis and Peritoneal Dialysis), and by End-User (Dialysis Centers, Specialty Clinics, and Hospitals) Forecast Period (2023-2030)
The global artificial kidney market is anticipated to grow at a considerable CAGR of 13.0% during the forecast period. The market growth is attributed to factors including the increasing number of patients suffering from diseases such as Acquired Cystic Kidney Disease, Glomerular Diseases, Diabetes Insipidus, and others, globally. Moreover, the less availability of kidney donors is another key factor intensifying the market growth. For instance, according to the Center for Disease Control and Prevention (CDC), in 2021 more than 1 in 7, that is 15% of US adults or 37 million people are diagnosed with chronic kidney disease (CKD).
The increasing R&D activities for manufacturing the innovative artificial kidney is anticipated to further bolster the growth of the artificial kidney market. For instance, in June 2021, UCLA Health published an article stating "Artificial Kidney in Development Aims to Offer Dialysis Free Life". As per the article, the US Department of Health and Human Services (HHS) partnered with the American Society of Nephrology (ASN) to accelerate innovation in the prevention, diagnosis and treatment of kidney diseases. For which, currently, both the organizations are working together to develop waterless, dialysate-free technology , supports in creating the 1st implantable artificial kidney by 2026.
The global artificial kidney market is segmented based on its device type, dialysis type, and end-user. Based on device type, the market is bifurcated into wearable artificial kidney and implantable artificial kidney. Based on dialysis type, the market is segmented into hemodialysis and peritoneal dialysis. Further, based on the end-user, the market is sub-segmented into dialysis centers, specialty clinics, and hospitals. Among the end-user, the hospitals sub-segment is anticipated to have a significant market share owing to the expansion of kidney disease related healthcare facilities and hospitals across the globe.
Among the dialysis type segment, hemodialysis is anticipated to hold a prominent market share of the global artificial kidney market. Hemodialysis is a treatment to filter wastes and water from the blood. It helps in controlling blood pressure (BP) and balance important minerals, such as potassium, sodium, and calcium, in blood. The segmental growth is attributed to the rising number of end-stage renal diseases (ESRD) along with the increasing incidences of diabetes and hypertension among the global population. According to the National Institute of Health (NIH), around 786,000 people in the US are living with ESRD in 2021. Of which, 71% are on dialysis and 29% are expected to opt kidney transplant.
The global artificial kidney market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the European region is anticipated to grow at a considerable rate in the artificial kidney market during the forecast period owing to the increasing healthcare expenditure coupled with the rising prevalence of kidney diseases. The general government health expenditure in the European Union (EU) region amounted nearly around $1.3 trillion in 2021, which is around 8% of the total gross domestic product of the region (GDP).
Global Artificial Kidney Market Growth, by Region 2023-2030
Source: OMR Analysis
Among all regions, the Asia-Pacific region is anticipated to account for a significant share of the artificial kidney market during the forecast period. Factors bolstering the market growth includes the increasing number of people suffering with chronic kidney diseases and increasing investment by regional key market players to enhance the production capacity of artificial kidneys. For instance, in December 2020, Japanese medical device manufacturer Nipro Asia spent around $958 million to ramp-up the global production facility of artificial kidneys used in dialysis machines. The investment, which runs through fiscal 2026, will go mainly toward factories in Vietnam and the home market. Total output capacity will reach 12 million units a month. This expansion will support Nipro's plans to boost dialyzer sales in emerging countries, where diabetes patients have increased with economic growth.
The major companies serving the global artificial kidney market include B. Braun Melsungen AG, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nikkiso Co. Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2022, Medtronic plc and DaVita Inc. partnered to form a new, independent kidney care-focused medical device company NewCoto enhance the patient treatment experience and improve overall outcomes.
The Report Covers:
Current Industry Analysis and Growth Potential Outlook
Global Artificial Kidney Market by End-User
Dialysis Centers